After passage of the Medicare prescription drug law in 2003, drug companies received windfalls worth billions of dollars, as a result of no longer applying rebates for dual-eligibles (beneficiaries who qualify for Medicare and Medicaid). Senator Rockefeller’s 2013 Medicare Drug Savings Act reverts back to previous law and recaptures the savings lost under the 2003 law. “By simply returning these beneficiaries to Medicaid-negotiated rebates, taxpayers would save $141.2 billion over the next ten years,” said Edward F. Coyle, Executive Director of the Alliance. The Rockefeller bill has 18 cosponsors listed here. Read the full Rockefeller press release and see a coalition letter of support here.